|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Carotid Atherosclerosis | |||||
| Cerebrovascular Accident | |||||
| Diabetes Mellitus | |||||
| Hypercholesterolemia | |||||
| Hypertension | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Atherosclerosis | |||||
| Carotid Artery Diseases | |||||
| Cerebral Infarction | |||||
| Stroke | |||||
| 3 | More general conditions related to this trial | ||||
| Arterial Occlusive Diseases | |||||
| Arteriosclerosis | |||||
| Brain Diseases | |||||
| Brain Infarction | |||||
| Brain Ischemia | |||||
| Cardiovascular Diseases | |||||
| Central Nervous System Diseases | |||||
| Cerebrovascular Disorders | |||||
| Dyslipidemias | |||||
| Endocrine System Diseases | |||||
| Glucose Metabolism Disorders | |||||
| Hyperlipidemias | |||||
| Lipid Metabolism Disorders | |||||
| Metabolic Diseases | |||||
| Nervous System Diseases | |||||
| Vascular Diseases | |||||
| 4 | Sponsors listed in this trial | ||||
| National Institute of Neurological Disorders and Stroke (NINDS) | |||||